Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...
Nandita Vijayasimha, Bengaluru Friday, October 17, 2025, 08:00 Hrs [IST] ...
Due to rising antimicrobial resistance, the treatment of complicated UTIs and acute pyelonephritis is becoming more difficult ...
(Nasdaq: SPRO) and GSK plc (LSE/NYSE: GSK) today announced efficacy and safety results of the positive pivotal phase 3 PIVOT-PO trial evaluating tebipenem HBr, an investigational oral treatment for ...
Highlights include clinical data from Phase 3 studies in Community Acquired Pneumonia (CABP) and microbiologic data from a Phase 2 study in nontuberculous mycobacterial pulmonary disease (NTM-PD) ...
New data presented at IDWeek 2025 by Japanese drugmaker Shionogi highlight the real-world effectiveness of cefiderocol in ...
There has been a cool breakthrough using "useless" gold. Researchers have discovered that gold nanoparticles can increase the ...
Background Blood culture (BC) in children has relatively low diagnostic yield and high contamination rates, limiting ...
Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not ...
Data highlighting potential of Nu-3 in mildly infected diabetic foot ulcer (iDFU) published in "Antimicrobial Agents and ...
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback